L. Alig

Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity.

Wolfgang Guba, Gisbert Schneider, Jochem Alsenz, 2008, Journal of medicinal chemistry.

Orally active fibrinogen receptor antagonists. 2. Amidoximes as prodrugs of amidines.

P. Hadváry, D. Knopp, S. Bunting, 1996, Journal of medicinal chemistry.

Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors.

L. Weber, D. Banner, M. Stahl, 2005, Bioorganic & medicinal chemistry letters.

Low molecular weight, non-peptide fibrinogen receptor antagonists.

P. Hadváry, A. Trzeciak, D. Knopp, 1992, Journal of medicinal chemistry.

Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors.

L. Weber, D. Banner, M. Stahl, 2005, Bioorganic & medicinal chemistry letters.

1B. Synthesis of biologically active steroids and related compounds 9. Synthesis of biologically active D-homopregnanes

L. Alig, Marcel Mueller, R. Wiechert, 1974 .

Fibrinogen receptor antagonists - a novel class of promising antithrombotics

L. Alig, M. Müller, B. Steiner, 1994 .

Phenethanolamine derivatives with calorigenic and antidiabetic qualities.

M. Meier, L. Alig, M. E. Bürgi-Saville, 1984, International journal of obesity.